NCT00000217

Brief Summary

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 1990

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 1996

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

September 20, 1999

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 21, 1999

Completed
Last Updated

April 16, 2015

Status Verified

April 1, 2015

Enrollment Period

6.1 years

First QC Date

September 20, 1999

Last Update Submit

April 15, 2015

Conditions

Cocaine-Related DisordersSubstance-Related Disorders

Keywords

drug abuse

Outcome Measures

Primary Outcomes (5)

  • Drug use

  • Effectiveness of medication

  • Level of pharm

  • Retention

  • Depression, anxiety

Interventions

CarbamazepineDRUG

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Please contact site for information.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

University of Kansas

Kansas City, Missouri, 64128, United States

Location

Related Publications (1)

  • J Addictive Dis. 13; 1994

    BACKGROUND

MeSH Terms

Conditions

Cocaine-Related DisordersSubstance-Related Disorders

Interventions

Carbamazepine

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

DibenzazepinesHeterocyclic Compounds, 3-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • William Haning, M.D.

    University of Kansas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Purpose
TREATMENT
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 1999

First Posted

September 21, 1999

Study Start

September 1, 1990

Primary Completion

October 1, 1996

Last Updated

April 16, 2015

Record last verified: 2015-04

Locations

US(1)